Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer; Sevrin, Chantal ; et alin Journal of Controlled Release (2012) Detailed reference viewed: 1 (0 ULg) Poly(2-dimethylamino ethylmethacrylate)-based polymers to camouflage red blood cell antigens.; ; et al in Biomacromolecules (2012), 13(4), 1172-80 Poly(2-dimethylamino-ethylmethacrylate) (PDMAEMA) is a cationic polymer when dissolved in a 7.4 pH fluid. Owing to its ionic nature, this polycation interacts with the negatively charged cell membrane ... [more ▼] Poly(2-dimethylamino-ethylmethacrylate) (PDMAEMA) is a cationic polymer when dissolved in a 7.4 pH fluid. Owing to its ionic nature, this polycation interacts with the negatively charged cell membrane surface of red blood cells (RBCs). The electrostatic self-assembly of PDMAEMA on RBCs membrane can be employed for inducing the formation of a polymeric shield camouflaging blood group antigens on RBCs as a valuable strategy for developing "universal RBCs" for blood transfusion. The purpose of this research was to evaluate the camouflaging ability of PDMAEMA homopolymers and PDMAEMA-co-poly(ethylene glycol) copolymers differing in molecular weight and architecture. Surprisingly, the PDMAEMAs caused a partially masking, no masking, and sensitization of the same RBCs population. The MW and architecture of the polymers as well as temperature of PDMAEMA-RBCs treatment influenced the results observed. Herein, the very particular reactivity of PDMAEMAs and RBCs is analyzed and discussed. [less ▲] Detailed reference viewed: 49 (4 ULg) PolyElectrolyte Complexes (PEC’s) tailored to promote the delivery of proteinaceous compoundsGrandfils, Christian ![]() Conference (2011, November 16) Detailed reference viewed: 1 (0 ULg) Effect of drug candidates for the treatment of Alzheimer's disorber on hippocampus-dependent learning, glutamate receptors and mitochondriaVignisse, Julie ; ; et alConference (2011, November 12) Detailed reference viewed: 1 (0 ULg) Characterization of the interaction between nanoformulated drugs and model lipid membranes towards improved drug delivery systems; ; Sevrin, Chantal et alPoster (2011, October 25) Detailed reference viewed: 2 (0 ULg) Characterization of the interaction between nanoformulated drugs and model lipid membranes towards improved drug delivery systems; ; Sevrin, Chantal et alPoster (2011, October) Detailed reference viewed: 4 (0 ULg) Characteristics of antitumor liposomess loaded with lipophilic prodrugs of methotrexate and mephalan in relation to their hemocompatibility; Sevrin, Chantal ; et alConference (2011, September 19) Detailed reference viewed: 2 (0 ULg) Inspired bio- nanobiomaterials for tissue engineeringGrandfils, Christian ![]() Conference (2011, September 19) Detailed reference viewed: 1 (0 ULg) Production of biodegradable polyesters from industrial and agricultural by-products; ; et al Conference (2011, September) Why biodegradable polymers for medical applications ? main applications ; list and properties of biodegradable polymers actually accepted for medical applications ; physico-chemical, mechanical factors affecting degradation of polymers.Grandfils, Christian ![]() Conference (2011, July 15) Detailed reference viewed: 3 (0 ULg) Nanoparticles tailored for the delivery of biopharmaceutic drugsGrandfils, Christian ; Sevrin, Chantal ; et alConference (2011, May 20) Detailed reference viewed: 2 (0 ULg) Biodegradable microcarrier with entrapped peptides for tissue engineering; ; Grandfils, Christian ![]() Conference (2011, May 05) Chitosan/polyester copolymers prepared by solid-phase synthesis as promising biomaterials; ; et al Conference (2011, May 05) Detailed reference viewed: 1 (0 ULg) Structural Rearrangements of Polymeric Insulin-loaded Nanoparticles Interacting with Surface-Supported Model Lipid Membranes; Grandfils, Christian ; et alin Journal of Biomaterials and Nanobiotechnology (2011) Detailed reference viewed: 1 (0 ULg) In vitro prescreening study of the hemoreactivity of polymeric nanocarriers designed for the delivery of biopharmaceutical drugsGrandfils, Christian ; Sevrin, Chantal ; et alScientific conference (2011, March 18) Detailed reference viewed: 3 (0 ULg) Dimebon Enhances Hippocampus-Dependent Learning in Mouse Models of Appetitive Y-Maze and Inhibitory Step-Down Memory Tasks in MiceVignisse, Julie ; ; et alPoster (2011, February 23) Dimebon, a compound recently proposed for a treatment of Alzheimer’s disorder, was suggested to have memory enhancing properties in pre-clinical and clinical studies. We investigated whether dimebon at ... [more ▼] Dimebon, a compound recently proposed for a treatment of Alzheimer’s disorder, was suggested to have memory enhancing properties in pre-clinical and clinical studies. We investigated whether dimebon at doses acutely (0.1 mg/kg and 0.5 mg/kg) or repeatedly (0.1 mg/kg) administered to mice via i.p. injections, increases memory scores respectively in an appetitive and an inhibitory learning task. Acute treatment with dimebon at the dose 0.1 mg/kg did not affect learning scores in 3-month-old C57BL/6N. Acute treatment with higher dose of dimebon (0.5mg/kg) was found to enhance inhibitory learning in 3-month-old mice as shown in the step-down avoidance paradigm in C57BL/6N mice. In a model of appetitive learning, a spatial version of the Y-maze, repeated treatment with dimebon increased the rate of correct choices and decreased the latency of accessing a water reward after water deprivation. Repeated administration of dimebon also increased the duration of drinking behaviour during training/testing procedures although water consumption behaviour was not altered. Additional behavioural tests were carried out to investigate possible non-specific effects of dimebon on parameters of drinking, anxiety and exploration/locomotion. Our data suggest that dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory tasks in mice. [less ▲] Detailed reference viewed: 13 (5 ULg) Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in miceVignisse, Julie ; ; et alPoster (2011, January 31) Dimebon, a compound recently proposed for a treatment of Alzheimer’s disorder was suggested to have memory enhancing properties in pre-clinical and clinical studies. We investigated whether dimebon at ... [more ▼] Dimebon, a compound recently proposed for a treatment of Alzheimer’s disorder was suggested to have memory enhancing properties in pre-clinical and clinical studies. We investigated whether dimebon at doses acutely (0.1 mg/kg and 0.5 mg/kg) or repeatedly (0.1 mg/kg) administered to mice via i.p. injections, increases memory scores respectively in an appetitive and an inhibitory learning task. Acute treatment with dimebon at the dose 0.1 mg/kg did not affect learning scores in either 3-month-old C57BL/6N or CD1 mice. Acute treatment with higher dose of dimebon (0.5mg/kg) was found to enhance inhibitory learning in 3- and 7-month-old mice as shown in the step-down avoidance paradigm in C57BL/6N mice. No effects on learning were seen in CD1 mice. In a model of appetitive learning, a spatial version of the Y-maze, repeated treatment with dimebon increased the rate of correct choices and decreased the latency of accessing a water reward after water deprivation. Repeated administration of dimebon also increased the duration of drinking behaviour during training/testing procedures although behaviours in others tests or water consumption were not altered. Acute treatment of water-deprived and non-water-deprived mice with dimebon also did not affect their water intake. Our data suggest that dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory tasks in mice. [less ▲] Detailed reference viewed: 5 (3 ULg) Design et évaluation de nouveaux biomatériaux pour la construction de tissusGrandfils, Christian ![]() Conference (2011, January 19) Hemocompatibility and biofunctionality of two poly(2- (dimethylamino)ethyl methacrylate-co-poly(ethyleneglycol) copolymers; ; et al in Journal of Biomedical Materials Research (2011), 99A (3) |
||